Wolverine Asset Management’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16
Closed -$40 1874
2025
Q2
$40 Hold
16
﹤0.01% 1581
2025
Q1
$60 Hold
16
﹤0.01% 1541
2024
Q4
$135 Buy
16
+11
+220% +$105 ﹤0.01% 1585
2024
Q3
$65 Buy
+5
New +$137 ﹤0.01% 1625
2023
Q1
Sell
-562
Closed -$167K 2132
2022
Q4
$167K Sell
562
-1,019
-64% -$301K ﹤0.01% 1180
2022
Q3
$461K Buy
1,581
+768
+94% +$224K 0.01% 1036
2022
Q2
$236K Buy
+813
New +$236K ﹤0.01% 1166

Other funds holding XAGE

Wolverine Asset Management's XAGE Position: Q3 2025 in Review

Wolverine Asset Management sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2025, closing a stake of 16 shares — an estimated $40 sold.

Wolverine Asset Management first reported a position in XAGE in Q2 2022 and held it in 7 quarters. The position peaked at $461K in Q3 2022. 3 funds tracked by Wall St. Rank hold XAGE as of Q3 2025.

  • Wolverine Asset Management reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 16 Longevity Health Holdings, Inc. Common Stock shares in Q3 2025, an estimated $40.
  • Wolverine Asset Management first reported a position in Longevity Health Holdings, Inc. Common Stock in Q2 2022 and held it in 7 quarters.
  • Wolverine Asset Management's Longevity Health Holdings, Inc. Common Stock position peaked at $461K in Q3 2022.
  • 3 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2025.

Based on Wolverine Asset Management's 13F filing for Q3 2025, filed 28 Oct 2025.